Japan Vaccine to Make All-Out Effort,“Invest All Resources” in Cervical Cancer, Rotavirus Vaccines

Japan Vaccine Chairman Toshihiro Ishikiriyama (L) and President Akira Nagano (R) Japan Vaccine Co., Ltd., a joint venture formed in April between Daiichi Sankyo and GlaxoSmithKline K.K. (GSK), will make an all-out effort to market the cervical cancer vaccine Cervarix...read more